Old Web
English
Sign In
Acemap
>
authorDetail
>
Myra Gilligan
Myra Gilligan
Merck & Co.
Chemistry
Biochemistry
Antagonist
Chemical synthesis
QT interval
6
Papers
128
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Non-basic ligands for aminergic GPCRs: the discovery and development diaryl sulfones as selective, orally bioavailable 5-HT2A receptor antagonists for the treatment of sleep disorders.
2010
Bioorganic & Medicinal Chemistry Letters
T. Ladduwahetty
Myra Gilligan
Alexander Charles Humphries
Kevin John Merchant
Rebecca L. Fish
George Mcalister
Magnus Ivarsson
María Domínguez
Desmond O’Connor
Angus Murray Macleod
Show All
Source
Cite
Save
Citations (10)
8-Fluoroimidazo[1,2-a]pyridine: Synthesis, physicochemical properties and evaluation as a bioisosteric replacement for imidazo[1,2-a]pyrimidine in an allosteric modulator ligand of the GABAA receptor
2006
Bioorganic & Medicinal Chemistry Letters
Alexander Charles Humphries
Emanuela Gancia
Myra Gilligan
Simon Charles Goodacre
David James Hallett
Kevin John Merchant
Steve Thomas
Show All
Source
Cite
Save
Citations (83)
Diaryl than 5-HT2A antagonist
2005
Pineiro Jose Luis Castro
Laura Catherine Cooper
Myra Gilligan
Alexander Charles Humphries
Peter Alan Hunt
Tamara Ladduwahetty
Angus Murray Macleod
Kevin John Merchant
Niel Monique Bodil Van
Kevin J. Wilson
Show All
Source
Cite
Save
Citations (0)
Derives de l'arylsulfonylnaphtalene utilises en tant qu'antagonistes de 5ht2a
2005
Mark Stuart Chambers
Neil Roy Curtis
Emanuela Gancia
Myra Gilligan
Alexander Charles Humphries
Tamara Ladduwahetty
Robert James Maxey
Kevin John Merchant
Show All
Source
Cite
Save
Citations (0)
1